Ernexa Therapeutics Announces 1-for-15 Reverse Stock Split
1. Ernexa announced a 1-for-15 reverse stock split effective June 12, 2025. 2. The split aims to comply with Nasdaq's minimum bid price of $1.00. 3. Post-split, shares will reduce from 110.4 million to approximately 7.36 million. 4. This move is part of Ernexa's strategy to strengthen its financial foundation. 5. The split was approved by stockholders on June 2, 2025.